PTH - Preemptive Treatment for Herpesviridae
Efficacy of a Preemptive Treatment by Ganciclovir or by Aciclovir in ICU Patients Requiring Prolonged Mechanical Ventilation and Presenting a Viral Replication (CMV and/or HSV) - Prospective, Randomized, Double-blinded Multicenter Trial
Sponsor: Assistance Publique Hopitaux De Marseille
Listed as NCT02152358, this PHASE4 trial focuses on Viral Pneumonia and remains completed. Sponsored by Assistance Publique Hopitaux De Marseille, it has been updated 9 times since 2014, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Oct 2021 — May 2023 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 4 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Aug 2018 — Aug 2019 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique Hopitaux De Marseille
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Marseille, France